Concerns and precautions for a patient living with chronic fibrosing ILD with progressive phenotype during the coronavirus pandemic.
Concerns and precautions for a patient living with chronic fibrosing ILD with progressive phenotype during the coronavirus pandemic.
Transcript:
Dawn Repola: On my own at home, I have a pulse oximeter that I use whenever I’m feeling like my oxygen might be low. That’s what I do personally, and of course I have my oxygen that I use. For the monitoring that is done for me at the clinic, I go in every 3 months. I have blood monitoring that happens on a monthly basis. I go in every 3 months, and I have pulmonary function tests each time I go in. Every 6 months I have a 6-minute walk test, and I have a high-risk CT [computed tomography] scan once a year. That’s the close look to see if there’s been progression.
COVID-19 [coronavirus disease 2019] for me is scary. Quite frankly, I’m terrified. I think it’s because there’s a lack of information, because this is something we’ve never experienced before, so we don’t have any good information. I tend to err on the side of caution. The precaution I’m taking is I’m a world champion at social distancing. Once I got the lesson around how immunosuppression means that you have to stay away from large crowds and sick people, and cold and flu season means you need to hang out at your home and be careful who you’re around and avoid situations where you might be exposed, social distancing for COVID-19 wasn’t that big of a deal for me.
For my friends who are extroverts, it was a big deal. But I was like, “Yeah, I live on Zoom anyway.” I communicate well outside that, so that wasn’t all that different. The thing that was different was having my husband do all the grocery shopping. I’m the cook, so that means I get some interesting ingredients that I have to deal with. It’s difficult to not be able to just go out to the store if you need to go out to get something. I don’t see that my life is that different in preparing and defending against COVID-19. I’m really looking forward to the time when we have good, reliable testing and good, reliable immunizations for the disease.
AI Meets Medicare: Inside CMS’s WISeR Model With Sanjay Doddamani, MD, MBA, Part 2
August 5th 2025In this second part of his interview with The American Journal of Managed Care®, Sanjay Doddamani, MD, MBA, a former senior advisor to CMMI and founder and CEO of Guidehealth, continues a dialogue on the future of value-based care and the promise—and limits—of AI-enabled innovation, reflecting on challenges like rising Medicare costs and patients’ growing financial burdens.
Read More
Chronic Respiratory Diseases Linked to Other Noncommunicable Diseases in Vulnerable Countries
August 4th 2025Despite their devastating global impact, chronic respiratory diseases remain a hidden threat in low- and middle-income countries, often going undiagnosed in adults who are already battling other noncommunicable diseases.
Read More
It Take a Village in Cancer Care: A Q&A With David Nguyen, MD
July 23rd 2025David Nguyen, MD, medical oncologist with Tufts Medicine and Lowell General Hospital, discusses the evolving landscape of advanced cancer treatments like chimeric antigen receptor T-cell therapy and bispecific antibodies
Read More
RSV's Impact on Heart Health Emphasizes Broader Risks, Vaccination Importance for Older Adults
July 23rd 2025Respiratory syncytial virus (RSV) poses a significant, often overlooked, risk for serious cardiovascular complications in older adults, underscoring the need for vaccination in this population regardless of their preexisting health conditions.
Read More